CLINICAL_TRIALS
trial_result
· 2020-06-16
Clinical Trial Update: Beta-blockers in Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 trial assessing beta-blockers in pulmonary arterial hypertension was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Minnesota | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2020-06-16